Illinois Department of Public Health receives $5.3M Hiv Care Formula Grants from the Health Resources and Services Administration
Illinois Department of Public Health | State of IllinoisIllinoisIllinois Department of Public Health received $5,310,652 from the Department of Health and Human Services under Hiv Care Formula Grants (93.917). This action is a new award. Funds can be spent from September 30, 2026 to September 29, 2027.
- This action
- $5,310,652
- Not the award total
- Action date
- Sep 10, 2026
- 63 days ago
- Program
- Hiv Care Formula Grants
- Assistance listing 93.917
- Spending window
- 11 months left
- Ends September 29, 2027
Reach the agencies that just got funded.
Get agency contacts freeFree account · 30-second setup · No credit card
Award details
- Recipient
- Illinois Department of Public Health
- Awarding agency
- Department of Health and Human Services
- Sub-agency
- Health Resources and Services Administration
- Awarding office
- HRSA Office of Federal Assistance Management
- Assistance type
- Grant
- Action
- NEW AWARD
- Period of performance
- September 30, 2026 to September 29, 2027
- Award ID (FAIN)
- X0855875
About this award
From the award's filing with the federal government.
Ryan white part b supplemental - the Illinois Department Of Public Health (idph) is applying for ryan white part b (rwpb) supplemental funding through opportunity HRSA-26-074 in recognition and anticipation of significant changes to its jurisdictions’ health care landscape (i.e. CY26 increases to marketplace and other commercial health plan premium expenditures; CY27 medicaid cuts and increased eligibility requirements). Changing health care landscapes combined with the program's regular, continual growth have led to concerns about considerable strain on the Illinois adap (ila) program, potentially leading to formulary restrictions, reductions in client income eligibility, and an adap waitlist. Idph is requesting $9 million in FY26 rwpb supplemental funds that will directly target program sustainability by supporting purchases of medication and insurance premiums for eligible clients. Ila is considered a hybrid medication assistance program (serving those insured and uninsured). Since FY23, ila has been stably operating the program while maximizing the quality and quantity of delivered service. In FY25, the program served about 30% of people with hiv in Illinois (see further prevalence data in attachment 6). This includes service to 11,420 clients with medication assistance and 3375 with premium assistance (medicare, marketplace, and other private insurance plans). The viral suppression rate among ila clients is approximately 94%. Current high-cost expenditures for premium assistance and anticipated cuts to medicaid, however, threaten the program’s ability to maintain viral suppression and optimal health among illinoisans living with hiv. Ila has thoughtfully planned and forecasted for anticipated challenges and has developed an approach to maintaining service delivery through strategic initiatives and partnerships. Ila needs rwpb supplemental funding to support anticipated new clients and will implement this grant in alignment with its commitment to HRSA standards if awarded. Combined with cost-saving strategies, rwpb supplemental funding would help the program delay or prevent service reductions. It may ultimately protect clients from being placed on an adap waitlist. This critical work is not only vital to the programmatic health of the ila but also to the health of all clients served.
From USAspending
This record comes from USAspending.gov, the federal government's public database of spending. It describes one action on the award, so the amount shown is not the award's total.
Transaction 7526_X0855875_X0855875-3183801186_93.917_00